FDA hurdles, capital raises if share price pops. Treat as a lotto ticket: less than 1% of portfolio in common shares—small ...

EBITDA for Q1 2025 was $13.6 million or 28% of revenue, compared to only $6.7 million, or 19% of revenue, for Q1 2024. The net income for Q1 2025 was $5.6 million, or $0.12 per share, compared to a ...

Copyright © 2025 MarketWatch, Inc. All rights reserved.